Ken-ichiro Yoshida

Mibu, 3210293, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: March 09, 2021

Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.

Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.

Journal: Cancer science

Published: January 28, 2021

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival.

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival.

Journal: Cancer immunology, immunotherapy : CII

Published: July 26, 2020

Surgical Injury and Ischemia Prime the Adipose Stromal Vascular Fraction and Increase Angiogenic Capacity in a Mouse Limb Ischemia Model.

Surgical Injury and Ischemia Prime the Adipose Stromal Vascular Fraction and Increase Angiogenic Capacity in a Mouse Limb Ischemia Model.

Journal: Stem cells international

Published: August 27, 2019

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density.

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density.

Journal: Cancer immunology, immunotherapy : CII

Published: July 19, 2019

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer.

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer.

Journal: BMC cancer

Published: January 18, 2019

Cancer-associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (VEGFA) in response to environmental stimuli.

Cancer-associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (VEGFA) in response to environmental stimuli.

Journal: Annals of gastroenterological surgery

Published: November 05, 2018

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis.

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis.

Journal: Oncotarget

Published: December 04, 2017

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.

Journal: BMC cancer

Published: September 29, 2017

Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer.

Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer.

Journal: Open heart

Published: May 30, 2017

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma.

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma.

Journal: Oncotarget

Published: March 17, 2017

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.

Journal: BMC cancer

Published: October 19, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026